Corrigendum to "Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study" [Sleep Med. 109 (2023) 65-74 ISSN 1389-9457].

Autor:	Bae CJ; Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zee PC; Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Leary EB; Jazz Pharmaceuticals, Palo Alto, CA, USA., Fuller DS; Jazz Pharmaceuticals, Philadelphia, PA, USA., Macfadden W; Jazz Pharmaceuticals, Philadelphia, PA, USA., Candler S; Jazz Pharmaceuticals, Philadelphia, PA, USA. Electronic address: Shawn.Candler@jazzpharma.com., Steininger TL; Jazz Pharmaceuticals, Palo Alto, CA, USA., Husain AM; Duke University Medical Center, Durham, NC, USA.
Jazyk:	angličtina
Zdroj:	Sleep medicine [Sleep Med] 2024 Jul; Vol. 119, pp. 17-18. Date of Electronic Publication: 2024 Apr 16.
DOI:	10.1016/j.sleep.2024.04.001
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect